The global production of Abacavir Sulfate Active Pharmaceutical Ingredient (API) is handled by a relatively limited number of focused manufacturers. Several firms across areas like Europe and the US hold significant shares in this essential segment of the pharmaceutical industry. Purity is of the utmost importance, necessitating stringent regulator